Amelia Wall Warner, CEO and Founder, of Global Specimen Solutions, Inc. has been named one of the top Women in Business by the Triangle Business Journal (TBJ) as a recipient of the 2017 Women in Business Awards. She was selected as one of 26 recipients of the award from an elite group of about 100 women who are successful leaders both in their business lives and through their service and commitment to the community. Amelia will be recognized by TBJ at an awards luncheon on April 21st.
Continue reading Amelia Wall Warner named as one of the top Women in Business by the Triangle Business Journal
March 20-21, 2017 | Sheraton Philadelphia Downtown Hotel | Philadelphia, PA
The rapid evolution of central lab capabilities has been catalyzed by the expansion and sophistication of diagnostic testing availability. Never before has it been more important to streamline diagnostic solutions to increase patient recruitment, develop personalized medicine, cross-validate test results, and ultimately optimize clinical trials. The 3rd Central Labs & Diagnostics Partnerships Forum addresses the challenges to streamlining clinical trial processes with innovative solutions, so you can maintain constant focus on deliverables.
This forum is the only educational conference designed to guide you to implement and execute central lab strategic partnerships; desegregate sponsor-site-lab activity; and assess central lab competency through its diagnostics array, precision medicine, cross-protocol analytics, and more!
AGENDA DAY ONE Monday, March 20, 2017
Solve Key Clinical Trial Challenges by Turning Specimen Data into Actionable Insights: Break the Data Silo Barrier with New Tools for Real-Time Data Analysis
- Integrate vendor and in-house data streams to enable new, actionable insights and a forward-oriented strategy
- Examine new solutions from Global Specimen Solutions and Covance that provide innovative approaches for specimen tracking and chain of custody throughout the specimen life cycle
- Learn about how unified views of specimen data and near-real-time analytics allow in-life interventions for advanced clinical trial execution.
- Respond quickly to regulatory challenges or adverse events through an ability to analyze data across your pipeline and query samples with codified informed consent at your fingertips
- Maximize the value of your specimens and enable access to live data and analytics.
John Spegele, Vice President of Central Laboratory Services, Business Solutions and Enterprise Program Management Office, COVANCE
Amelia Wall Warner, Pharm.D., R.Ph., CEO and Founder, GLOBAL SPECIMEN SOLUTIONS, INC.
GSS will be attending Advanced Analytics for Clinical Data 2017 February 1 – 2 in San Francisco, CA. The Advanced Analytics for Clinical Data meeting provides an opportunity to meet with peers from across the industry who are successfully implementing advanced analytics to accelerate clinical R&D.
Visit the Advanced Analytics for Clinical Data website to learn more about the event.
RALEIGH, NC (PRWEB) OCTOBER 13, 2016
Global Specimen Solutions (GSS) today announced a five-year strategic alliance with Covance, the drug development business of Laboratory Corporation of America® Holdings (LabCorp®) (NYSE:LH). Covance’s market-leading central laboratory will offer GSS products GlobalCODE® and snapTRACK™ to its pharmaceutical and biotechnology clients to provide streamlined global specimen tracking, as well as informed consent and assay result management that will deliver actionable insights from specimens across development programs. Covance will be the exclusive lab to offer GSS’s services for pharmaceutical development.
Read the Full Press Release Here
Triangle Biotech Research Symposium V
October 11, 2016
North Carolina Biotechnology Center, Research Triangle Park
The BioPharma Research Council (BRC) brings together scientists across the many silos of biomedical research. This year the Triangle Biotech Research symposia of BRC will focus on D3D: Data, Drugs, Diagnostics. D3D aims to provide a platform for exploring the remarkable opportunities impacted by new perspectives on data generation and analysis.
CEO of Global Specimen Solutions, Inc., Amelia Warner, will be presenting at this conference.
Click Here to Learn More
October 6 – 7, 2016
Partnership in Clinical Trials focuses on clinical trials outsourcing, procurement, operations, and innovation as well as the disruptive technologies that will make your trials faster, better, and more cost-effective. Come see GSS’ COO/CFO Tom Wollman present ‘The Impact of In-Life Actionable Data on Clinical Trials Execution’ on October 6 as well as chair that afternoon’s session.
Biorepositories and Sample Management focuses on specimen management, informed consent precision medicine, next generation sequencing, and the final common rule. Come see Amelia Warner chair the morning sessions on Oct 6 and 7 and listen to her presentation on entitled ‘Making biobank data e-Valuable’ at 11am.
Click Here to Learn More
New article on the American Society for Clinical Pharmacology & Therapeutics provides a cross-industry review of the complexity of informed consent for translational research conducted across jurisdictions in global research programs. Amelia Warner, CEO of Global Specimen Solutions, Inc. is a contributing Author.
Click Here to Read the Full Article
CEO of GSS, Amelia Warner, participated in the first Kayo Women in Healthcare Investing Conference in Durham Tuesday night. GSS was one of seven women-led startups in NC highlighted at the conference. The startups were highlighted because they are led by women and have worked to make key innovations in healthcare. Amelia was thrilled to be a part of the event.
Click Here to Learn More About the Conference
CHARLESTON, SOUTH CAROLINA (PRWEB) NOVEMBER 09, 2015
Advanced Precision Medicine, Inc. (APM), a commercialization catalyst for molecular diagnostics, today announced that it has engaged the services of a specialty specimen management clinical research organization, Global Specimen Solutions, Inc. (GSS), to qualify innovative molecular diagnostics for inclusion in the Syner-G portfolio of molecular diagnostics. APM’s Syner-G portfolio of molecular diagnostics includes applications in oncology, autoimmunity, wellness, and pain management.
Read Advanced Precision Medicine, Inc.’s Press Release Here
Continue reading Advanced Precision Medicine, Inc. engages Global Specimen Solutions, Inc. to identify molecular diagnostics for commercial launch in U.S. CLIA labs
Bringing disruptive innovation into the marketplace is exciting for a new company. Day to day, innovation, process/product improvement and enhancement consume the start-up employee’s time, thoughts, and performance. Working in this culture is rewarding, fast-paced, and ever changing.
Continue reading Driving Disruptive Innovation- The Importance of Knowing Your Potential Customer